Young women at greater risk for adverse outcomes following PCI

Women younger than 55 years of age who undergo percutaneous coronary intervention for acute coronary syndrome are more likely to experience one-year adverse cardiovascular events due to risk factors such as diabetes and chronic kidney disease, yet they are less likely to receive potent antiplatelet therapy than men.
Source: Health Medicine Science Daily